Posted On: 09/28/2014 1:49:58 AM
Post# of 30082
TB,
Thanks. I appreciate it.
Yeah, I saw that. So, back in July they said the company "intends" ...
http://finance.yahoo.com/news/amarantus-amend...00893.html
Sept. 12th PR says...
http://ir.amarantus.com/company-news/detail/1...mpro-testr
expects to release data on the predictive value of individual LymPro markers (univariate) from the full cohort of 72 patients in the coming weeks.
"We look forward to releasing additional univariate data from the originally-planned 72 patient LP-002 clinical study in the near-term," said Gerald E. Commissiong, President & CEO of Amarantus.
Yet again people putting a date on an event that was NEVER scheduled.
Interesting, but not really. Can't wait to see the self inflicted wounds of disappointment, again. But too bad I won't. The whole Block option is a beautiful thing.
Cheers & Many Returns
Thanks. I appreciate it.
Yeah, I saw that. So, back in July they said the company "intends" ...
http://finance.yahoo.com/news/amarantus-amend...00893.html
Sept. 12th PR says...
http://ir.amarantus.com/company-news/detail/1...mpro-testr
expects to release data on the predictive value of individual LymPro markers (univariate) from the full cohort of 72 patients in the coming weeks.
"We look forward to releasing additional univariate data from the originally-planned 72 patient LP-002 clinical study in the near-term," said Gerald E. Commissiong, President & CEO of Amarantus.
Yet again people putting a date on an event that was NEVER scheduled.
Interesting, but not really. Can't wait to see the self inflicted wounds of disappointment, again. But too bad I won't. The whole Block option is a beautiful thing.
Cheers & Many Returns
(0)
(0)
